SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Mehdi Hamadani, Parameswaran N. Hari, Ying Zhang, Jeanette Carreras, Görgün Akpek, Mahmoud D. Aljurf, Ernesto Ayala, Veronika Bachanova, Andy I. Chen, Yi-Bin Chen, Luciano J. Costa, Timothy S. Fenske, César O. Freytes, Siddhartha Ganguly, Mark S. Hertzberg, Leona A. Holmberg, David J. Inwards, Rammurti T. Kamble, Edward J. Kanfer, Hillard M. Lazarus, David I. Marks, Taiga Nishihori, Richard Olsson, Nishitha M. Reddy, David A. Rizzieri, Bipin N. Savani, Melhem Solh, Julie M. Vose, Baldeep Wirk, David G. Maloney, Sonali M. Smith, Silvia Montoto, Wael Saber, Early Failure of Frontline Rituximab-Containing Chemo-immunotherapy in Diffuse Large B Cell Lymphoma Does Not Predict Futility of Autologous Hematopoietic Cell Transplantation, Biology of Blood and Marrow Transplantation, 2014, 20, 11, 1729

    CrossRef

  2. 2
    Vijaya Raj Bhatt, Julie M. Vose, Hematopoietic Stem Cell Transplantation for Non-Hodgkin Lymphoma, Hematology/Oncology Clinics of North America, 2014, 28, 6, 1073

    CrossRef

  3. 3
    Douglas A. Stewart, Reinhard Kloiber, Carolyn Owen, Nizar J. Bahlis, Peter Duggan, Adnan Mansoor, Isabelle Bence-Bruckler, Results of a prospective phase II trial evaluating interim positron emission tomography-guided high dose therapy for poor prognosis diffuse large B-cell lymphoma, Leukemia & Lymphoma, 2014, 55, 9, 2064

    CrossRef

  4. 4
    Christophe Fruchart, Hervé Tilly, Franck Morschhauser, Hervé Ghesquières, Marie Bouteloup, Christophe Fermé, Eric Van Den Neste, Dominique Bordessoule, Reda Bouabdallah, Alain Delmer, René Olivier Casasnovas, Loïc Ysebaert, Renaud Ciappuccini, Josette Briere, Christian Gisselbrecht, Upfront Consolidation Combining Yttrium-90 Ibritumomab Tiuxetan and High-Dose Therapy with Stem Cell Transplantation in Poor-Risk Patients with Diffuse Large B Cell Lymphoma, Biology of Blood and Marrow Transplantation, 2014, 20, 12, 1905

    CrossRef

  5. 5
    Sylvia Hoeller, Alexandar Tzankov, Frank Stenner, Stephan Dirnhofer, When and how to test for C-MYC in aggressive B cell lymphomas, Journal of Hematopathology, 2014,

    CrossRef

  6. 6
    S. Hu, Z. Y. Xu-Monette, A. Balasubramanyam, G. C. Manyam, C. Visco, A. Tzankov, W.-m. Liu, R. N. Miranda, L. Zhang, S. Montes-Moreno, K. Dybkaer, A. Chiu, A. Orazi, Y. Zu, G. Bhagat, K. L. Richards, E. D. Hsi, W. W. L. Choi, J. Han van Krieken, Q. Huang, J. Huh, W. Ai, M. Ponzoni, A. J. M. Ferreri, X. Zhao, J. N. Winter, M. Zhang, L. Li, M. B. Moller, M. A. Piris, Y. Li, R. S. Go, L. Wu, L. J. Medeiros, K. H. Young, CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study, Blood, 2013, 121, 14, 2715

    CrossRef

  7. You have free access to this content7
    Peter Kristian Rasmussen, Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: An investigation of clinical and histopathological features, Acta Ophthalmologica, 2013, 91, thesis5
  8. 8
    Ying Huang, Sheng Ye, Yabing Cao, Zhiming Li, Jiajia Huang, He Huang, Muyan Cai, Rongzhen Luo, Tongyu Lin, Outcome of R-CHOP or CHOP Regimen for Germinal Center and Nongerminal Center Subtypes of Diffuse Large B-Cell Lymphoma of Chinese Patients, The Scientific World Journal, 2012, 2012, 1

    CrossRef

  9. 9
    Marco Gunnellini, Rita Emili, Stefano Coaccioli, Anna Marina Liberati, The Role of Autologous Stem Cell Transplantation in the Treatment of Diffuse Large B-Cell Lymphoma, Advances in Hematology, 2012, 2012, 1

    CrossRef